| Oryzon

Skip to main content

English
Español

Company
- Overview
- Strategy
- Team
Epigenetics
- Epigenetics
- LSD1
Programs
Patients
- Clinical Trials
Investors
News & Events
- Press releases
- Events
Contact

Search

Breadcrumb

Home

9-10 March 2021

H.C. Wainwright Global Life Sciences Conference

9-14 March 2021

15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021

16-18 February 2021

2021 BIO CEO & Investor Digital Conference

10 February 2021

ORYZON to present new clinical data and corporate updates at conferences in February and March

4-22 January 2021

ACCESS CHINA Forum @JPM Week 2021

26-28 January 2021

Edison’s Open House – Global Healthcare 2021

6-11 January 2021

LifeSci Advisors’ 10th Annual LifeSci Advisors Corporate Access Event 2021

11-14 January 2021

H.C. Wainwright Bioconnect Conference

4 January 2021

ORYZON to present a corporate update and to hold multiple virtual corporate activities in January-2021

17 December 2020

ORYZON Launches Pioneering Schizophrenia Precision Medicine Study In Collaboration With Columbia Psychiatry

Pagination

First page «
Previous page ‹
Page 23
Page 24
Page 25
Page 26
Current page 27
Page 28
Page 29
Page 30
Page 31
Next page ›
Last page »

Subscribe to

Company

Overview
Strategy
Team

Epigenetics

Epigenetics
LSD1

Programs

Pipeline
Iadademstat
Vafidemstat
Collaborations
Publications

Patients

Clinical Trials

Investors

Share Information
Financial Information
CNMV Filings
Analyst Coverage
Corporate Governance
Corporate Social Responsibility

News & Events

Press releases
Events

Contact

Contact
Email Alerts
Join us

© Oryzon Genomics, S.A. - All Rights Reserved

Legal
Privacy Policy
Cookie Policy
Ethics Channel